Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

10.1097/NEN.0b013e3181919a48

10.1007/BF00308809

10.1016/S0197-4580(97)00056-0

10.1007/s00401-006-0127-z

Thal, 2000, Sequence of Ab-protein deposition in the human medial temporal lobe, J Neuropathol Exp Neurol, 59, 733, 10.1093/jnen/59.8.733

10.1212/WNL.58.12.1791

Alafuzoff, 2008, Staging of neurofibrillary pathology in Alzheimer's disease: A study for the BrainNet Europe Consortium, Brain Pathol, 18, 484, 10.1111/j.1750-3639.2008.00147.x

10.1007/s00401-010-0789-4

10.1073/pnas.90.11.5066

Trojanowski, 2000, "Fatal attractions” of proteins, A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann N Y Acad Sci, 924, 62

10.1126/science.1132814

Goedert, 2006, Tau protein, the paired helical filament and Alzheimer's disease, J Alzheimers Dis, 9, 195, 10.3233/JAD-2006-9S323

Mattson MP . Molecular and cellular pathways towards and away from Alzheimer's disease. In: Jucker M Beyreuther K Haass C Nitsch R Christen Y , eds. Alzheimer: 100 Years and Beyond . Berlin, Germany: Springer, 2006:371–78

10.1111/j.1750-3639.2007.00053.x

10.1159/000283478

Dickson, 2009, Neuropathology of non-Alzheimer degenerative disorders, Int J Clin Exp Pathol, 25, 1

10.1016/0304-3940(87)90204-7

10.1093/brain/awm305

10.1016/S0072-9752(07)01251-1

10.1111/j.1750-3639.1991.tb00661.x

10.1016/S0197-4580(02)00065-9

10.1007/s00401-010-0664-3

10.1097/NEN.0b013e3181c6c13d

10.1016/0306-4522(87)90123-0

10.1016/0165-0173(89)90017-9

10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q

10.1111/j.1365-2990.2008.00997.x

10.1097/NEN.0b013e31816a1df3

10.1111/j.1365-2990.2009.01038.x

10.1002/ana.410240210

10.1016/S0197-4580(97)00035-3

10.1001/archneur.60.3.337

10.1146/annurev.neuro.28.061604.135709

10.1111/j.1440-1789.2006.00725.x

10.1016/j.neurobiolaging.2006.02.007

10.1159/000113716

10.2174/156720508784533286

10.1038/nrn2573

10.1016/0306-4522(83)90023-4

10.1016/S0006-8993(98)00441-7

10.1097/00005072-199902000-00008

10.1007/BF00293315

10.1146/annurev.pathmechdis.2.010506.092044

10.1038/nature08983

10.1523/JNEUROSCI.4521-10.2010

10.1007/s12035-010-8137-1

10.1111/j.1750-3639.2009.00326.x

Patten, 2010, Reactive oxygen species: Stuck in the middle of neurodegeneration, J Alzheimers Dis, 20, 357, 10.3233/JAD-2010-100498

10.1016/0197-4580(94)90031-0

10.1007/s00401-011-0826-y

10.1016/0306-4522(95)90397-P

10.1002/ana.21509

10.1006/nbdi.1996.0003

10.1006/exnr.1997.6777

Del, 2008, Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign, Commentary on “No disease in the brain of a 115-year-old woman.” Neurobiol Aging, 29, 1133

10.1007/s00401-007-0207-8

10.2174/156720508785132307

10.1007/s00401-009-0486-3

10.1007/s00401-010-0716-8

10.1083/jcb.200108057

10.1007/s004019900178

Hardy JA . The amyloid hypothesis: History and alternatives. In: Jucker M Beyreuther K Haass C , eds. Alzheimer: 100 Years and Beyond . Berlin, Germany: Springer, 2006:151–56

10.1126/science.1072994

10.1016/j.neurobiolaging.2003.12.015

10.1016/j.neurobiolaging.2003.09.009

10.1016/j.jalz.2007.11.008

10.1016/j.biocel.2008.12.015

10.1016/S1474-4422(09)70299-6

10.1126/science.1062097

10.1126/science.1058189

10.1016/j.neuron.2004.07.003

10.1371/journal.pone.0016648

10.1007/s00401-011-0825-z

10.1016/j.tins.2010.04.003

10.1074/jbc.M110.209296